Foghorn Therapeutics Inc. (FHTX) is a publicly traded company in the Unknown sector. Across all available filings, 11 corporate insiders have executed 48 transactions totaling $8.3M, demonstrating a bullish sentiment with $1.5M in net insider flow. The most recent transaction on Sep 23, 2024 involved a sale of 857 shares valued at $8.7K.
No significant insider buying has been recorded for FHTX in the recent period.
No significant insider selling has been recorded for FHTX in the recent period.
Based on recent SEC filings, insider sentiment for FHTX is bullish with an Insider Alignment Score of 59/100 and a net flow of $1.5M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at Foghorn Therapeutics Inc. (FHTX) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 11 insiders are actively trading FHTX stock, having executed 48 transactions in the past 90 days. The most active insider is Samuel Agresta (Executive), who has made 2 transactions totaling $3.7M.
Get notified when executives and directors at FHTX file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Sep 23, 2024 | Costa Carlos | Executive | Sale | 857 | $10.17 | $8.7K | 10b5-1 |
| Sep 23, 2024 | Costa Carlos | Executive | Option Exercise | 857 | $3.72 | $3.2K | 10b5-1 |
| Sep 20, 2024 | Costa Carlos | Executive | Option Exercise | 35,756 | $3.72 | $133.0K | 10b5-1 |
| Sep 20, 2024 | Costa Carlos | Executive | Sale | 35,756 | $10.04 | $359.0K | 10b5-1 |
| Sep 18, 2024 | Costa Carlos | Executive | Sale | 11,574 | $10.05 | $116.3K | 10b5-1 |
| Sep 18, 2024 | Costa Carlos | Executive | Option Exercise | 11,574 | $3.72 | $43.1K | 10b5-1 |
| Sep 17, 2024 | Costa Carlos | Executive | Sale | 10,272 | $10.04 | $103.1K | 10b5-1 |
| Sep 17, 2024 | Costa Carlos | Executive | Option Exercise | 10,272 | $3.72 | $38.2K | 10b5-1 |
| Sep 16, 2024 | Costa Carlos | Executive | Sale | 400 | $10.00 | $4.0K | 10b5-1 |
| Sep 16, 2024 | Costa Carlos | Executive | Option Exercise | 400 | $3.72 | $1.5K | 10b5-1 |
| Sep 9, 2024 | F. Bellon Steven | Executive | Sale | 20,000 | $9.50 | $190.0K | 10b5-1 |
| Mar 11, 2024 | Cavalie Fanny | Executive | Sale | 11,000 | $6.56 | $72.2K | |
| Aug 17, 2023 | Gottschalk Adrian | Executive | Gift | 63,000 | $N/A | $0 | |
| Aug 17, 2023 | Gottschalk Adrian | Executive | Gift | 63,000 | $N/A | $0 | |
| Aug 16, 2023 | Agresta Samuel | Executive | Sale | 311,297 | $8.25 | $2.6M | Large |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Purchase(P) | 5 | $4.9M | 47.5% |
Sale(S) | 8 | $3.4M | 33.3% |
Exercise(M) | 14 | $2.0M | 19.2% |
Gift(G) | 10 | $0 | 0.0% |
Other(J) | 4 | $0 | 0.0% |
Conversion(C) | 7 | $0 | 0.0% |
Insider activity at Foghorn Therapeutics Inc. shows mixed signals across all time. While $4.9M in purchases indicates some executive confidence,$3.4M in sales balances the picture, resulting in a modest net flow of $1.5M.11 insiders have been active, with no strong directional conviction evident in the aggregate data. The most active insider, Samuel Agresta, has transacted $3.7M during this period.